Perceived Burden of Completion of Patient-Reported Outcome Measures in Clinical Trials: Results of a Preliminary Study Bodart, S B B, Crescioni, M E S,, Flood, E and on behalf of the ePRO C. Perceived Burden of Completion of Patient-Reported Outcome
Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments
January 6, 2018 Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
January 6, 2018 Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop
January 6, 2018 Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium
New Collaboration Seeks to Speed Huntington’s Disease Drug Licensing This article originally appeared on HDBuzz and is reprinted here under Creative Commons license. Critical Path Institute launches
March 14, 2018 Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin
August 3, 2018 Quantitative Approach for Cardiac Risk Assessment and Interpretation in Tuberculosis Drug Development
February 28, 2018 Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices
